1Fernandez LA,Pope B,Lee C,et al.Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line.Blood,1986,67(4):925-930.
2Koizumi S,Seki H,Tachinami T,et al.Malignant clonal expansion of large granular lymphocytes with a Leu-11 +,Leu-7-surface phenotype:in vitro responsiveness of malignant cells to recombinant human interleukin 2.Blood,1986,68(5):1065-1073.
3Imamura N,Kusunoki Y,Kawa-Ha K,et al.Aggressive natural killer cell leukaemia /lymphoma:report of four cases and review of the literature.Possible existence of a new clinical entity originating from the third lineage of lymphoid cells.Br J Haematol,1990,75(1):49-59.
4Ryder J,Wang X,Bao L,et al.I Aggressive natural killer cell leukemia:report of a Chinese series and review of the literature.Int J Hematol,2007,85(1):18-25.
7Tani R,Ozaki S,Kosaka M,et al.Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia.Br J Haematol,1999,106(3):709-712.
8Makishima H,Ito T,Asano N,et al.Significance of chemokine receptor expression in aggressive NK cell leukemia.Leukemia,2005,19(7):1169-1174.
9Makishima H,Ito T,Momose K,et al.Chemokine system and tissue infiltration in aggressive NK-cell leukemia.Leuk Res,2007,31(9):1237-1245.
10Lay JD,Tsao CJ,Chen JY,et al.Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.J Clin Invest,1997,100(8):1969-1979.
2Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumor. Pathology and genetics. Tumors of hematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer Press, 2001.
3Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol, 1990, 75: 49-59.
4Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol, 2007, 139: 532-544.
2Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells[J]. Br J Haematol,1990 ,75 (1) :49 -59.
3Nava VE,Jaffe ES. The pathology of NK-Cell lymphomas and leukemias[J]. Adv Anat Pathol,2005,12( 1 ) :27-34.
4Ko YH, Park S, Kim K, et al. Aggressive natural killer cell leukemia :is Epstein-Barr virus negativity an indicator of a favorable prognosis? [ J ]. Acta Haematol,2008,120 (4) : 199 - 206.
5Patel AP, Ghatak SB, Patel JA. Long term survival in aggressive NK cell leukemia[J]. Indian Pediatr,2010,47 (9) :807 - 808.
6Jaccard A, Petit B, Giraut S,et al. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature[J]. Ann Oncol,2009,20 ( 1 ) : 110 -116.
7Sasaki M, Sugimoto K, Kawahara S,et al. Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK-eell leukemia [J]. Eur J Haematol, 2007,78 ( 6 ) : 545.
9SUZUKI R,SUZUMIYA J,NAKAMURA S’ et al.Hematopoietic stem cell transplantation for naturalkiller-cell lineage neoplasms[J], Bone Marrow Trans-plant,2006 ,37:425 - 431.
